National Health Investors INC

National Health Investors, Inc. has appointed Christian Maingot as Chief Operating Officer, effective July 27, 2026, to enhance long-term growth and operational capabilities.

National Health Investors, Inc. has completed the sale of 35 healthcare facilities to NHC/OP, L.P., a subsidiary of National HealthCare Corporation, for $560 million.

National Health Investors, Inc. has entered into a Change in Control Severance Agreement with executive Todd Siefert, effective July 1, 2026, outlining benefits in the event of termination following a change in control.

National Health Investors announces early termination of HSR waiting period for a significant property sale, with closing anticipated around July 1, 2026.

National Health Investors, Inc. successfully concluded its 2026 Annual Meeting with shareholders electing all director nominees and ratifying its independent auditor.

National Health Investors, Inc. (NHI) provided an investor update on May 4, 2026, including a press release and investor presentation detailing business performance and outlook.

National Health Investors, Inc. (NHI) reported its first quarter 2026 financial results, showing increased rental income and resident fees, alongside strategic portfolio adjustments.

Care YBE Subsidiary LLC guarantees National Health Investors' senior notes.

National Health Investors, Inc. announced increased revenues and net income for Q2 2025, driven by new investments and strategic portfolio rebalancing.

National Health Investors (NHI) announces its Q1 2025 financial results, highlighting growth driven by recent strategic investments in senior housing and medical facilities.

National Health Investors (NHI) reported its third quarter 2024 results, showing a slight increase in rental income but facing challenges with certain tenants and increased loan loss provisions.

National Health Investors (NHI) announced its second quarter 2024 financial results, highlighting growth in rental income and senior housing operations.

National Health Investors, Inc. (NHI) reported a 12.1% increase in total revenues to $375.6 million for the fiscal year ended December 31, 2025, driven by new acquisitions and growth in its Senior Housing Operating Portfolio (SHOP) segment.

National Health Investors, Inc. (NHI) reports its financial results for the year ended December 31, 2024, highlighting strategic investments and operational performance.

National Health Investors has filed an amendment to its 2023 annual report to include the audited financial statements of Senior Living Communities, LLC, a significant lessee.

National Health Investors, Inc. outlines its capital stock structure, REIT compliance measures, and various risk factors in its annual 10-K filing.

Christian Ken Maingot, Chief Operating Officer of National Health Investors Inc, received 2,370 shares of common stock on July 27, 2026.

National Health Investors director Robert A. McCabe Jr. purchased 890 shares of common stock at $71.6485 per share.

National Health Investors director James R. Jobe reported a gift of 225 shares of common stock.

National Health Investors CEO D. Eric Mendelsohn purchased 1,500 shares of common stock at $68.84 per share.

National Health Investors Inc. CFO John L. Spaid reported a transaction involving the withholding of shares for tax obligations.

National Health Investors Inc. reports a transaction where CEO Eric Mendelsohn sold shares to cover tax obligations.

National Health Investors, Inc. reported strong 2025 performance, exceeding guidance with significant growth in Normalized FFO and FAD, and announced its 2026 Annual Meeting of Stockholders.

National Health Investors (NHI) is urging shareholders to vote for its director nominees, disagreeing with a recommendation from Institutional Shareholder Services (ISS) that NHI believes would jeopardize the company's superior shareholder returns.

Leading proxy advisory firm Egan-Jones recommends National Health Investors (NHI) stockholders vote for all of NHI's director nominees at the upcoming Annual Meeting.

National Health Investors, Inc. has filed a definitive proxy statement with the SEC.

National Health Investors (NHI) is urging stockholders to vote for its board nominees at the upcoming annual meeting, highlighting superior shareholder returns and a refreshed board.

Land & Buildings is soliciting proxies to elect its two nominees to the board of National Health Investors, aiming to address what it perceives as archaic corporate governance and conflicts of interest.

BlackRock, Inc. has disclosed a beneficial ownership of 17.6% in National Health Investors Inc. as of June 30, 2026.

Vanguard Capital Management has reported beneficial ownership of 5.11% of National Health Investors Inc.'s common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 8.6% of National Health Investors Inc.'s common stock as of March 31, 2026.